EN
HI

Akums Drugs & Pharmaceuticals Share price

AKUMS

HealthcareMid

571.4

0.30 (0.05%)
NSE
BSE
Last updated on 30 May, 2025 | 15:52 IST
BUYSELL
Today's High

576.65

Today's Low

565.05

52 Week Low

405.00

52 Week High

1175.90

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Chart

Akums Drugs & Pharmaceuticals Share Key Metrics

Volume
2.99 L
Market Cap
8993.49 CR
LTQ@LTP
27@571.40
ATP
570.37
Var Margin
19.55 %
Circuit Range
514-628.2
Delivery %
51.35 %
Value
17.05 CR
ASM/GSM
No
Market Lot
1

Akums Drugs & Pharmaceuticals Futures & Options

Data Not Found

Akums Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2025-05-26Audited Results
2025-02-06Quarterly Results
DateEvent TypeAgenda
2025-05-26Board MeetingAudited Results
2025-02-06Board MeetingQuarterly Results

Akums Drugs & Pharmaceuticals News

No Data Found

About Akums Drugs & Pharmaceuticals

NSE : 24715  
BSE : 544222  
ISIN : INE09XN01023  

Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Akums Drugs & Pharmaceuticals Management

NamePosition
Mr. Sanjeev Jain Managing Director
Mr. Sandeep Jain Managing Director
Mr. Sanjay Sinha Whole Time Director
Mr. Sunil Kumar Thakur Non Exe. & Nominee Director
Ms. Matangi Gowrishankar Independent Director
Read More

Akums Drugs & Pharmaceuticals FAQs

The Buying Price of Akums Drugs & Pharmaceuticals share is 571.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Akums Drugs & Pharmaceuticals share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 26.58. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 2.95. Useful to assess the stock's value relative to its book value.

To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 37.02 & 3.95 with sector averages, along with growth rates and financial metrics.

The Market Cap of Akums Drugs & Pharmaceuticals is 8993.49 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 1175.90 & 405.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.